We are live on ! Find out more
AHCO icon

AdaptHealth

210 hedge funds and large institutions have $1.31B invested in AdaptHealth in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 60 increasing their positions, 83 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,068% more call options, than puts

Call options by funds: $29.3M | Put options by funds: $925K

87% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 23

58% more capital invested

Capital invested by funds: $830M → $1.31B (+$480M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

9% more funds holding

Funds holding: 192210 (+18)

2.15% more ownership

Funds ownership: 83.46%85.61% (+2.2%)

28% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 83

Holders
210
Holders Change
+18
Holders Change %
+9.38%
% of All Funds
3.02%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
43
Increased
60
Reduced
83
Closed
23
Calls
$29.3M
Puts
$925K
Net Calls
+$28.4M
Net Calls Change
+$26.3M

AHCO Hedge Fund Activity: Q1 2024 in Review

210 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q1 2024, worth a combined $1.31B — up 58% from $830M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new AHCO positions and 23 closed out — a net gain of 20 holders — while 60 added to existing stakes and 83 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.95M. The largest seller was Fidelity Investments, cutting an estimated $23.7M.

  • 210 institutional investors held AdaptHealth (AHCO) as of Q1 2024, up from 192 in Q4 2023.
  • Funds reported $1.31B of AdaptHealth stock for Q1 2024, up 58% quarter-over-quarter.
  • 43 funds opened new AdaptHealth positions in Q1 2024 and 23 closed out, a net change of +20 holders.
  • The largest AdaptHealth buyer in Q1 2024 was Vanguard Group, an estimated $6.95M added.
  • The largest AdaptHealth seller in Q1 2024 was Fidelity Investments, an estimated $23.7M sold.

Based on aggregated 13F filings for Q1 2024.